{
    "clinical_study": {
        "@rank": "109452", 
        "arm_group": [
            {
                "arm_group_label": "Group A(heparin group)", 
                "arm_group_type": "Active Comparator", 
                "description": "Group A (n = 70) are put on Inj. UFH (Cal-heparin) 5000 U subcutaneous twice daily plusAspirin 81 mg/day (Juspirin)  with the \ufb01rst positive pregnancy test, Inj. UFH is given either into anterior abdominal wall or anterior aspect of thigh subcutaneously"
            }, 
            {
                "arm_group_label": "Group B", 
                "arm_group_type": "No Intervention", 
                "description": "group B (n = 70) receive no thing"
            }
        ], 
        "brief_summary": {
            "textblock": "Objective To determine maternal and fetal outcomes in women with APS managed with aspirin or\n      unfractionated heparin (UFH) plus aspirin during pregnancy.\n\n      Design: prospective clinical controlled study. Setting: high-risk pregnancy unit- Benha\n      university hospital. Methods: Pregnant women with recurrent miscarriage attending high-risk\n      pregnancy unit. 140 selected patients with previous recurrent miscarriage are divided into 2\n      groups: group A (n = 70)  receive low-dose aspirin (81 mg once daily orally) plus heparin\n      (5000 IU) every 12 h with the \ufb01rst positive pregnancy test while group B (n = 70)  receive\n      no thing .\n\n      Main outcome measures: Maternal outcomes included thromboembolic and haemorrhagic\n      complications and pregnancy-induced hypertension .Prematurity, intrauterine growth\n      restriction and neonatal death were considered as maternal and fetal complications"
        }, 
        "brief_title": "Pregnancy Outcomes in Women With Recurrent Miscarriage Treated With Low Dose Aspirin and Unfractionated Heparin", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Recurrent Miscarriage", 
        "condition_browse": {
            "mesh_term": [
                "Abortion, Spontaneous", 
                "Abortion, Habitual"
            ]
        }, 
        "detailed_description": {
            "textblock": "This prospective comparative, controlled clinical study is conducted at Department of\n      Obstetrics and Gynecology, Benha University Hospital, and a private center, from June 2012 .\n      After approval of the study protocol by the Local Ethical Committee and obtaining written\n      fully informed patients' consents. All patients are interviewed about their medical,\n      personal, family, obstetrical and thrombosis history. All patients included in study\n      complain of  three or more unexplained consecutive spontaneous abortions.\n\n      All patients (n=140)  are in good general health without previous history of Diabetes\n      Mellitus or thyroid dysfunction or cardiac disease. Patients with Thrombocytopenia\n      (<100000/ml), bleeding tendencies, ectopic pregnancy, past history of vascular thrombosis\n      ,uterine anomalies and multiple gestation are excluded from the study.\n\n      complete  blood  picture, urine routine examination, blood sugar, blood grouping, Bleeding\n      Time, Clotting Time, Prothrombin Time, Activated Partial Thromboplastin Time, Hepatitis B\n      Surface Ag, Hepatitis C Virus screening are offered to all patients and findings noted as\n      soon as they conceived. All patients are given routine Folic Acid, Iron and Calcium\n      supplementation orally daily during antenatal period (whether conceived spontaneously or\n      with treatment\n\n      140 selected patients with previous recurrent miscarriage are divided into 2 groups:Group A\n      (n = 70) are put on Inj. UFH (Cal-heparin) 5000 U subcutaneous twice daily plus Aspirin 81\n      mg/day (Juspirin)  with the \ufb01rst positive pregnancy test, Inj. UFH is given either into\n      anterior abdominal wall or anterior aspect of thigh subcutaneously. While group B (n = 70)\n      receive no thing"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with recurrent pregnancy loss (RPL)\n\n        Exclusion Criteria:\n\n          -  previous history of Diabetes Mellitus or thyroid dysfunction or cardiac disease\n\n          -  Thrombocytopenia (<100000/ml)\n\n          -  bleeding tendencies\n\n          -  ectopic pregnancy\n\n          -  past history of vascular thrombosis\n\n          -  uterine anomalies\n\n          -  multiple gestation"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "46 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02144064", 
            "org_study_id": "khalid-ahmed 3"
        }, 
        "intervention": {
            "arm_group_label": "Group A(heparin group)", 
            "description": "Group A (n = 70) are put on Inj. UFH (Cal-heparin) 5000 U subcutaneous twice daily plusAspirin 81 mg/day (Juspirin) with the \ufb01rst positive pregnancy test, Inj. UFH is given either into anterior abdominal wall or anterior aspect of thigh subcutaneously", 
            "intervention_name": "Heparin plus aspirin", 
            "intervention_type": "Drug", 
            "other_name": [
                "cal-heparin 5000 U", 
                "juspirin"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Aspirin", 
                "Heparin", 
                "Calcium heparin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Aspirin, heparin, pregnancy, recurrent miscarriage", 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "contact": {
                "email": "dr.khalidkhader77@yahoo.com", 
                "last_name": "khalid mohamed", 
                "phone": "201281469651"
            }, 
            "facility": {
                "address": {
                    "city": "Benha", 
                    "country": "Egypt", 
                    "state": "El Qualyobia", 
                    "zip": "13518"
                }, 
                "name": "Benha univesity hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pregnancy Outcomes in Women With Recurrent Miscarriage Treated With Low Dose Aspirin and Unfractionated Heparin", 
        "overall_contact": {
            "email": "dr.khalidkhader77@yahoo.com", 
            "last_name": "khalid mohamed", 
            "phone": "201281469651"
        }, 
        "overall_official": [
            {
                "affiliation": "Department of Obstetrics and Gynecology, Benha University Hospital", 
                "last_name": "khalid mohamed", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Benha faculty of medicine", 
                "last_name": "ahmed saad", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Egypt: Ministry of Higher Education", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "evidence of abortion is assessed clinically by vaginal bleeding and passage of contents of conception through vagina or by ultrasound through detecting missed abortion .", 
            "measure": "miscarriage", 
            "safety_issue": "Yes", 
            "time_frame": "during first  20 weeks of gregnancy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02144064"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Benha University", 
            "investigator_full_name": "khalid abd aziz mohamed", 
            "investigator_title": "lecturer of ob/gyn", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Maternal outcomes include thromboembolic and hemorrhagic complications and pregnancy-induced hypertension.these outcomes is assessed clinically by follow up mother throughout pregnancy e.g frequent blood pressure monitoring", 
                "measure": "Maternal outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "during 40 weeks of pregnancy"
            }, 
            {
                "description": "delivery of babies before fetal maturity which necessitate admission to the neonatal unit", 
                "measure": "prematurity", 
                "safety_issue": "Yes", 
                "time_frame": "after 20 weeks and before 37 weeks gestation"
            }, 
            {
                "description": "Foetal growth is monitored by fundal height measurement and serial ultrasounds. Doppler umbilical wave flow velocity is studied for foetuses with suspected intrauterine growth retardation", 
                "measure": "fetal outcome", 
                "safety_issue": "Yes", 
                "time_frame": "during last half of pregnancy(last 20 weeks)"
            }
        ], 
        "source": "Benha University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Benha University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}